Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples